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doi:10.1016/j.jmii.2011.01.002Background: Several elements in colostrum and humanmilk, including antibodies and nonspecific
factors with bactericidal and antiviral activity, may play an important anti-infectious and protec-
tive role. In developing countries, enterotoxigenic Escherichia coli (ETEC) is the main etiological
agent of diarrhea in low-socioeconomic level children. In the present work, we studied the func-
tional activity ofmononuclear (MN) and polymorphonuclear (PMN) phagocytes of human colostrum
against ETEC, as well as the interactions between these cells and colostral or serum opsonins.
Methods: Colostrum samples were collected from 33 clinically healthy women between 48 and 72
hours postpartum. We verified superoxide release in colostral MN and PMN using cytochrome C
reduction methods, phagocytosis, and bactericidal activity using acridine orange methods and
superoxide dismutase (SOD) in the colostrum supernatants.
Results: Colostral MN and PMN phagocytes exposed to ETEC opsonized with colostrum superna-
tants caused a significant increase (p< 0.05) in superoxide release. Phagocytosis by colostral
PMN cells increased significantly (p< 0.5) when the phagocytes were incubated with both sources
of opsonins (sera and colostrum). Increases in superoxide release in the presence of opsonized
bacteria triggered the bactericidal activity of the phagocytes. Phagocyte treatment with SOD
decreased their ability to eliminate ETEC. Colostrum supernatant had higher SOD concentrations
(p< 0.05) compared with normal human sera.Biological Sciences and Health, Federal of University of Mato Grosso, Rodovia MT 100, Km 3,5 s/no,
azil.
(A.C. Honorio-Franc¸a).
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2 E.L. Franc¸a et al.Conclusions: These results suggest that the ability of phagocytes to eliminate ETEC depends on
the activation of cellular oxidative metabolism; moreover, activation of colostral phagocytes is
likely an additional breast-feeding protection mechanism against intestinal infections in infants.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
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Colostrum is a rich source of nutrients containing several
immunological components, antioxidants, and bioactive
substances that play an important role in infant protection
against gastrointestinal and respiratory infections.1 Acute
diarrhea is the second main cause of death in low-socio-
economic level infants in developing countries.2 Enter-
otoxigenic Escherichia coli (ETEC) is a major causative agent
of death from diarrhea in children under five years of age.3
Many studies have shown that colostrum and human milk
contain important protective factors that combat pathogens
in children.4e8 Human milk is particularly rich in secretory
immunoglobulin A (sIgA),5 which blocks bacterial adherence
to human epithelial cells;7 neutralizes toxins;9 prevents viral
infections;10 and acts as an opsonin by increasing free radi-
cals, phagocytosis, and the microbicidal activity of colostral
cells.4,11 The protective role of colostral IgA and human milk
has been shown for various microorganisms.4,12
In addition to antibodies, soluble bioactive components,
and anti-infectious factors, human colostrum contains large
amounts of viable leukocytes (1 109 cells/mL in the first
days of lactation), especially macrophages and neutro-
phils.13 In addition to circulating leukocytes, these cells
produce free radicals and have phagocytic and bactericidal
activity.14 In bacterial infections, phagocytes are known to
be the main cell lineage in host defense.15
Colostral macrophages have phagocytic activity, express
IgA receptors (FcaR; CD89),11,16 and produce oxygen-free
radicals.17 The bactericidal activity of colostral mono-
nuclear (MN) phagocytes after opsonization with sIgA is
equivalent to that of MN and polymorphonuclear (PMN)
phagocytes from peripheral blood.4 Colostral neutrophils,
in turn, have lower phagocytic and bactericidal activity
compared with the peripheral neutrophils.18 The IgA
receptors that the neutrophils express are free of gamma
chain associations (g-less FcaR) and may mediate the
noninflammatory effects of sIgA.11 Therefore, the main role
of sIgA is likely related to maternal protection.19
Human milk contains antibodies against a variety of
bacteria, and colostrum inhibits the adhesion of different
ETEC serotypes.8 Components other than immunoglobulins
(i.e. oligosaccharides, glycoproteins, and glycolipids) also
seem to prevent the adhesion of ETEC strains to host cells.8
Phagocytes in human colostrum possibly act in conjunction
with soluble components, thereby providing an additional
protection mechanism against enterobacterial infection.
However, studies on the functional activity of colostral MN
and PMN phagocytes and their interactions with the
bioactive components of colostrum are only partially
understood. Considering that ETEC accounts for child
diarrhea worldwide, this study aimed at evaluating thepotential of colostral MN and PMN phagocytes for elimi-
nating ETEC as well as the interaction between this path-
ogen and soluble elements of colostrum.
Materials and methods
Subjects
After an informed consent was obtained, around 15 mL of
colostrum was collected from clinically healthy women,
18e35 years of age, between 48 and 72 hours postpartum4
at the Human Milk Bank of the Center for Female Care,
Araxa´, Minas Gerais (nZ 23) and at the Health System
Program of Barra do Garc¸as, Mato Grosso (nZ 10). All the
procedures were analyzed and approved by the Research
Ethics Committee of the “Centro Universita´rio do Planalto
de Araxa´”, Araxa´, Minas Gerais, Brazil.
Separation of colostral cells
Colostrum samples were collectedmanually in sterile plastic
tubes and centrifuged (160g, 4C) for 10 minutes. Centri-
fugation separated colostrum into three different phases:
cell pellet, an intermediate aqueous phase, and a lipid-
containing supernatant, as described by Honorio-Franc¸a
et al.4 Cells were separated by a Ficoll-Paque gradient
(Pharmacia, Upsala, Sweden), producing preparations with
95% of pure PMN cells and 98% of pure MN cells, analyzed by
light microscopy. Purified neutrophils and macrophages
were resuspended independently in serum-free medium 199
at a final concentration of 2 106 cells/mL.
Escherichia coli strain
The ETEC used was the ETEC 14e057:H7 serotype, provided
by the Laboratory of Immunology of Intestine Mucosa of the
Biomedical Sciences Institute of the University of Sa˜o Paulo,
Brazil. The stock culture was cultivated in trypic soy broth
(Difco Laboratories, Detroit, MI, USA) for 18 hours at 37C.
Bacteria were washed twice in phosphate-buffered saline
and adjusted to an approximate concentration of 1 108
bacteria/mL as measured by turbidimetry at 540 nm, using
a spectrophotometer (Femto, Sa˜o Paulo, Brazil). This
bacterial concentration was previously determined by
colony unit counting on trypic soy agar (Difco Laboratories,
Detroit, MI, USA).
Opsonin sources
Colostrum supernatantda pool of 10 colostral samples
[immunoglobulin concentration (g/L): IgAZ 7.4, IgGZ 0.15,
Colostral phagocytes eliminate ETEC 3and IgMZ 0.37] was defatted by repeated centrifugation at
160g for 10minutes, at 4C and used for ETEC opsonization.
Serada pool of normal human serum samples from 10
volunteer donors [immunoglobulin concentration (g/L):
IgAZ 2.64, IgGZ 14.0, and IgMZ 2.0] was prepared and
used for ETEC opsonization.
Bacterial opsonization
The opsonization of ETEC was achieved according to the
technique described by Bellinati-Pires et al.20 Colostrum
supernatants and sera from 10 individuals were collected,
pooled, and frozen at 70C. Immediately before use,
colostral and serum aliquots were thawed and mixed with
appropriate volumes of bacterial suspension to a final
concentration of 2 107 bacteria/mL in 10% of the opsonin
sources. Another bacterial suspension prepared at the same
concentration in medium 199 without opsonin was used as
an untreated bacterial control. Both bacterial suspensions
were incubated for 30 minutes at 37C and used in the
bactericidal assays.
Release of superoxide anion
Superoxide release was measured by determining cyto-
chrome C (Sigma, St Louis, USA) reduction as previously
described.4,21 Briefly, MN and PMN phagocytes and
bacteria, opsonized or not, were mixed and incubated for
30 minutes for phagocytosis. Cells were then resuspended
in phosphate-buffered saline containing 2.6 mM CaCl2,
2 mM MgCl2, and cytochrome C (2 mg/mL). Phorbol myr-
istate acetate stimulation was performed as control at
0.5 mg/mL. The suspensions (100 mL) were incubated for 60
minutes at 37C on culture plates. The reaction rates were
measured by absorbance at 550 nm and the results were
expressed as nmol/O2
. All the experiments were performed
in duplicate or triplicate.
Bactericidal assay
Microbicidal activity and phagocytosis were evaluated using
the acridine orange method described by Bellinati-Pires
et al.20 Equal volumes of bacteria and cell suspensions were
mixed and incubated for 30minutes at 37C under continuous
shaking and in the presence or absence of superoxide dis-
mutase (SOD; 140 units).22,23 Phagocytosis was stopped by
incubation in ice. To eliminate extracellular bacteria, the
suspensions were centrifuged twice (160g, 10 minutes, 4C),
and the cellswere resuspended in serum-freemedium199and
centrifuged. The supernatantwasdiscardedand the sediment
dyed with 200 mL of acridine orange (14.4 g/L) for 1 minute.
The sediment was resuspended in cold culture 199, washed
twice, and observed under immunofluorescence microscope
at 400 and 1,000 magnification. The phagocytosis index
was calculated by counting the number of cells ingesting at
least three bacteria in a pool of 100 cells. To determine the
bactericidal index, we stained the slides with acridine orange
and counted 100 cells with phagocytized bacteria. The
bactericidal index is calculated as the ratio between orange
stained (dead) and green stained (alive) bacteria 100.20 All
the experiments were performed in duplicate or triplicate.CuZn-SOD concentration (CuZn-SODdE.C.1.15.1.1)
The CuZn-SOD enzyme concentration was determined in
sera (nZ 10) and colostrum (nZ 10) samples using the
nitroblue tetrazolium test (NBT; Sigma, St Louis, USA.) and
spectrophotometrically read at 560 nm.24,25
A 0.5 mL volume of sera or colostrum samples was
placed in test tubes, and 0.5 mL of standard hydroalcoholic
solutions (1:1 v/v) were prepared in other tubes. Both
samples of sera/colostrum and the standard solutions were
added to 0.5 mL of chloroform-ethanol solution (1:1 ratio)
followed by 0.5 mL of a reactive mixture of NBT and dia-
minoethanetetraacetic acid at a 1:1.5 ratio (v/v). After
2.0 mL of carbonate buffer plus hydroxylamine were
added, pH increased to 10.2.24 The tubes remained at room
temperature for 15 minutes and underwent spectrophoto-
metrical reading. The reactive mixture reached zero values
(for 3.5 mL). The SOD was calculated by the following
relationship: SODZ (Ab standardAb sample/Ab stand-
ard) 100Z % reduction of NBT/CuZn-SOD. The results
were expressed in international units of CuZn-SOD.
Statistical analysis
We used analysis of variance to evaluate superoxide anion
release, phagocytosis, and the bactericidal index according
to the presence or absence of opsonized ETEC, in phago-
cytes with or without SOD treatment and in MN and
PMN phagocytes. Student’s t test was used to analyze SOD
enzyme concentration for two independent samples. We
considered p values< 0.05 to be statistically significant.
Results
Superoxide release by colostral phagocytes in the
presence of ETEC opsonized with colostrum
supernatant
Colostrum MN and PMN phagocytes exposed to ETEC opson-
ized with colostrum supernatant increased superoxide
release compared with phagocytes exposed to bacteria
opsonized with normal human sera and phorbol myristate
acetate-stimulated cells (Table 1). When phagocytes were
incubated with nonopsonized ETEC, the superoxide released
by MN phagocytes was higher than that of PMN and equal to
that released as phagocytes when exposed to bacteria
opsonized by human sera. PMN phagocytes exposed to non-
opsonized ETEC had levels of superoxide release similar to
those of spontaneous release (Table 1).
Phagocytosis activity of colostrum MN and PMN cells
against ETEC opsonized by colostrum supernatant
Colostrum MN and PMN phagocytes have phagocytic activity
for ETEC. In the presence of opsonins (colostrum superna-
tant or normal sera), phagocytosis increased significantly.
Both sources of opsonins induced equivalent phagocytosis
rates by colostral MN and PMN (Fig. 1A and B). To verify the
effects of superoxide release on the phagocytosis of ETEC,
the phagocytic activity of colostral MN and PMN was
Table 1 Superoxide release by colostrum MN and PMN
phagocytes in the presence or absence of ETEC
Phagocytes Superoxide release (nmol/O2
)
MN PMN
Spontaneous
(without bacteria)
11.5 0.7 11.6 0.6
PMA (without bacteria) 15.8 0.9** 14.7 0.6**
Bacteria incubated with
medium 199
15.0 1.1** 11.4 1.1*
Bacteria opsonized with
colostrum pool
21.7 0.6** 16.3 0.7*,**
Bacteria opsonized with
a serum pool
15.7 0.8** 14.0 0.8**
Bacteria were opsonized with a colostrum supernatant pool or
a normal serum pool. In control assays, MN and PMN cells were
preincubated with medium 199. The results represent the
mean  standard deviation of 8 experiments with cells from
different individuals.
*p< 0.05 comparing cell type, considering the same opsonin
source.
**p< 0.05 comparing the treated groups with spontaneous
superoxide released, considering the same cell type.
ETECZ enterotoxigenic Escherichia coli; MNZmononuclear;
PMAZ phorbol myristate acetate; PMNZ polymorphonuclear.
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Figure 1. Bacterial phagocytosis by colostral (A) MN and (B)
PMN cells. Effects of SOD on ETEC phagocytosis by colostral
phagocytes. Bacterial phagocytosis by MN or PMN cells from
colostrum was determined using the acridine orange method in
thepresenceor absenceof SOD (140units). Results represent the
mean  standard deviation of five experiments with cells from
different individuals. *p< 0.05 comparing the opsonized groups
with the control groups, using a same SOD treatment or not.
ETECZ enterotoxigenic Escherichia coli; MNZmononuclear;
PMNZ polymorphonuclear; SODZ superoxide dismutase.
4 E.L. Franc¸a et al.analyzed in the presence of SOD, an enzyme that metabo-
lizes anion superoxide. As shown in Fig. 1A and B, phago-
cytosis index did not change when MN or PMN phagocytes
were incubated in the presence of SOD.
Elimination of ETEC opsonized with colostrum
supernatant by colostral MN and PMN phagocytes
Colostral MN and PMN phagocytes exerted bactericidal
activity against ETEC. When the bacteria were opsonized
with colostrum supernatant or normal sera, cell activity
enhanced significantly (p< 0.05). Both sources of opsonins
(colostrum supernatant or normal sera) induced equivalent
ETEC elimination rates (Fig. 2). When the cells were pre-
incubated in the presence of SOD, decreased bactericidal
activity (nonopsonized bacteria) was observed in both types
of cell. ETEC opsonized with colostrum supernatant in the
presence of MN or PMN phagocytes and preincubated with
SOD had lower bactericidal activity. No effects of SOD were
observed in ETEC elimination by PMN phagocytes using
serum-opsonized bacteria (Fig. 2).
CuZn-SOD concentration in human colostrum
supernatant
CuZn-SOD concentrations in colostrum supernatant
increased significantly (p< 0.05) compared with CuZn-SOD
levels in sera (Fig. 3).
Discussion
In the present study, we show that colostral phagocytes
significantly eliminate ETEC and that this activity isdependent on prooxidative cell metabolism. ETEC is the
main cause of diarrhea in developing countries, accounting
for 800 million deaths a year, mainly in children under the
age of 5 years.26
Breastfeeding has been described as an effective inter-
vention for infant protection, especially against respiratory
and gastrointestinal infections.27 Several studies have
shown that the phagocytic and microbicidal activity of
colostrum phagocytes12 is comparable with that of blood
phagocytes,13 with similar rates of phagocytosis and
bactericidal function.4
Earlier studies have shown that colostrum supernatant
contains components that activate the prooxidative
mechanisms of cells.4 The microbicidal activity of
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Figure 2. Bacterial elimination by colostral (A) MN or (B)
PMN cells. Action of SOD on ETEC elimination by colostral
phagocytes. Bacterial elimination by MN or PMN cells from
colostrum was determined using acridine orange methods in
the presence or absence of SOD (140 units). Results represent
the mean  standard deviation of five experiments with cells
from different individuals. *p< 0.05 comparing the opsonized
groups to the control groups, using a same SOD treatment or
not; **p< 0.05 comparing the SOD-treated group to the same
opsonin source. ETECZ enterotoxigenic Escherichia coli;
MNZmononuclear; PMNZ polymorphonuclear; SODZ super-
oxide dismutase.
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Figure 3. Concentration (mean standard deviation) of
CuZn-SOD in human sera and colostrum obtained in eight
experiments. SODZ superoxide dismutase.
Colostral phagocytes eliminate ETEC 5colostrum phagocytes has been linked to the activation of
cellular oxidative metabolism and release of large amounts
of free radicals, an extremely important phenomenon
during immune responses and inflammatory reactions.28
The results of this study confirm the importance of
superoxide anion for bacterial death. The increase in
superoxide release affects phagocytic and bactericidal
activity because SOD-treated phagocytes decrease ETEC
elimination. Other studies found that heat-inactivated SOD
does not affect the microbicidal activity of phagocytes.
Similarly, heat-inactivated SOD fails to block peroxidase
inhibitors.29
Superoxide anion production, phagocytosis, and the
microbicidal activity of MN and PMN phagocytes was higherin the presence of bacteria previously opsonized with
colostrum supernatant or normal sera. The immunoglobu-
lins and their complements, in particular IgG and C3b,
which are the main opsonins in the blood,30 are also found
in smaller amounts in human milk and colostrum.31 Other
studies have already reported the elimination of opsonized
enteropathogenic Escherichia coli by MN phagocytes but
not by PMN phagocytes.4 In the case of MN phagocytes,
microbicidal activity was stimulated only in the presence of
opsonins or other immunomodulatory agents.4
The functional activity of colostral PMN has been shown
to be lower than that of both human blood PMN and
colostral MN.32 But in the present study, PMN and MN
phagocytes had similar responses against ETEC previously
opsonized with colostrum supernatant or sera. Although IgG
is the predominant antibody type in sera, it is found in
lower amounts in colostrum, as are proteins from the
complement system.17
Both colostral MN and PMN phagocytes had higher super-
oxide release and microbicidal activity in the presence of
ETEC previously opsonized with colostrum supernatant.
Because IgA is the predominant antibody class in colostrum,6
this finding suggests that IgA is the opsonin that stimulates
microbicidal activity by both types of phagocytes in human
colostrum. The significance of the biological activity of IgA,
such as opsonin in colostrum secretion, is likely associated to
the formation of a complete microenvironment in which
soluble and cellular components act together.4
An interesting point is that colostrum phagocytes
exposed to nonopsonized ETEC had low bactericidal
activity. Some studies report that these cells have
decreased bactericidal activity because they lack nonspe-
cific receptors on their surface. Hence, bacteria that are
incubated with phagocytes may not be phagocytized and
thus remain outside these cells.4 The fact that colostral MN
phagocyte activity is opsonin dependent strengthens the
hypothesis of an interaction between soluble and cellular
components from colostrum, with phagocytes playing
a fundamental role in this interaction.
6 E.L. Franc¸a et al.According to our data, the release of superoxide anion
was higher in MN phagocytes than in PMN phagocytes, and
this difference was more marked when ETEC was previously
opsonized with colostrum supernatant. The bactericidal
activity of MN phagocytes was also higher in the presence of
ETEC previously opsonized with colostrum supernatant, as
shown in Fig. 2. Similar results were found for the MN cells
of Giardia lamblia12 and enteropathogenic Escherichia
coli,4 whose phagocytic ability increased after exposure to
a large amount of opsonins, suggesting that this cell type is
functionally more active, especially after opsonization.6
The activation mechanisms of human colostrum phago-
cytes may depend on stimulatory signals generated by
complement proteins and antibodies in milk, especially
IgA, complement receptor, and Fc receptor.33e35 The
combined action of these factors mediates signals that
lead to degranulation, oxygen radical production, and
phagocytosis.35
Human colostrum and milk are rich in biologically
active molecules that are essential for antioxidant func-
tions. A number of milk enzymes are important as immune
protectors.6 In the present study, cellular activation
produced a significant amount of superoxide, which is
essential for microbicidal activity. SOD concentration in
colostrum was higher than in human sera. Their soluble
and cellular components act in a child’s gut without,
however, provoking an inflammatory response.36 The
activity of SOD in human milk appears to be 10e25 times
higher than in sera36 and may change significantly during
lactation to meet the different needs of newborn devel-
opment.37 Other studies show that the highest activity of
this enzyme in milk occurs at three weeks of lactation and
that it decreases after 4 months of lactation.37 The anti-
oxidant capacity of colostrum, which is vital for the
newborn in the first days of life, is higher than that of
transition and mature milk.1
The activation of human colostral phagocytes by opsonins
and consequent release of superoxide anion is an important
mechanism for child protection. This secretion exhibits high
SOD enzyme content, which likely underlies phagocyte
action and avoids inflammatory reactions in a child’s intes-
tine. The lack of antioxidant defenses may trigger an inten-
sification of oxidative actions that culminate in a series of
diseases, especially in premature infants.38
Owing to the immaturity of the immune system of
newborns, many immunological components are not
completely developed.5 Human milk not only provides
passive immunity but can also directly modulate the
immune development of the child.39 Because of the
noninvasive characteristics of ETEC, a protective immune
response to the infection caused by this pathogen is likely
mediated by the mucosal immune system.40 There are
many significant immune components in human milk, and
these factors interact with each other, acting synergisti-
cally and providing protection to the newborn.5,14 The
number of viable cells and bioactive substances in the
colostrum suggests that this secretion is important to
protect the child. Because of the immature gastrointestinal
system in newborns, cells received through the colostrum
are not eliminated by digestive enzymes and remain intact
in the intestinal mucosa for 4 hours, participating actively
in bacteria elimination.41,42Colostrum phagocytes exert bactericidal activity against
ETEC through interactions with soluble factors in colos-
trum. The functional activity of phagocytes described in
this work reinforces the findings of other studies that
demonstrate the importance of breastfeeding in combating
these enterobacteriaceae.8,43 ETEC diarrhea affects mainly
children under the age of 2 years, and its incidence
decreases over time.44
The ability of phagocytes to eliminate ETEC depends on
the activation of cellular oxidative metabolism; in addition,
activation of colostral phagocytes is likely an additional
breast-feeding protection mechanism for infants against
intestinal infections and may represent an important source
of protection against infections during this phase of life and
may persist until maturity of the infant’s immune system is
well developed.
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